Korro Bio, Inc./$KRRO
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Korro Bio, Inc.
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability. The company operates and manages its business as one reportable segment and one operating segment, which is the business of discovering, developing and commercializing therapies derived from or incorporating its RNA-editing technology.
- Ticker
- $KRRO
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 57
- Headquarters
- Cambridge, United States
- Website
- www.korrobio.com
Korro Bio, Inc. Metrics
BasicAdvanced
$217M
-
-$7.51
-
-
Price and volume
Market cap
$217M
52-week high
$36.79
52-week low
$5.20
Average daily volume
206K
Financial strength
Current ratio
7.3
Quick ratio
7.036
Long term debt to equity
0.435
Total debt to equity
0.47
Interest coverage (TTM)
-24.83%
Profitability
EBITDA (TTM)
-74.366
Gross margin (TTM)
-634.91%
Net profit margin (TTM)
-8,214.47%
Operating margin (TTM)
-5,891.49%
Effective tax rate (TTM)
-1.05%
Revenue per employee (TTM)
$20,000
Management effectiveness
Return on assets (TTM)
-30.73%
Return on equity (TTM)
-113.26%
Valuation
Price to revenue (TTM)
161.458
Price to book
2.29
Price to tangible book (TTM)
2.29
Price to free cash flow (TTM)
-3.266
Free cash flow yield (TTM)
-30.62%
Free cash flow per share (TTM)
-4.516
Growth
Revenue change (TTM)
-82.47%
Earnings per share change (TTM)
-20.34%
3-year earnings per share growth (CAGR)
-14.38%
What the Analysts think about Korro Bio, Inc.
Analyst ratings (Buy, Hold, Sell) for Korro Bio, Inc. stock.
Analyst projections of the future price of Korro Bio, Inc. stock.
Korro Bio, Inc. Financial Performance
Revenues and expenses
Korro Bio, Inc. Earnings Performance
Company profitability
Upcoming events
No upcoming events
Funds containing Korro Bio, Inc.
Fund name | Fund size | $KRRO weighting |
|---|---|---|
SPDR Russell 2000 US Small Cap€R2US | $5.3B | 0.01% |
SPDR Russell 2000 US Small Cap£R2SC | $5.3B | 0.01% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.